today's posted documents

Asian Pacific Americans in the United States Congress -- Click to view this document
Congressional Liaison Offices of Selected Federal Agencies -- Click to view this document
House Committee Party Ratios: 98th-113th Congresses -- Click to view this document
Financial Market Supervision: Canada's Perspective -- Click to view this document
Sage Grouse and the Endangered Species Act (ESA) -- Click to view this document
Sexual Orientation and Gender Identity Discrimination in Employment: A Legal Analysis of the Employment Non-Discrimination Act (ENDA) -- Click to view this document
The Workforce Investment Act and the One-Stop Delivery System -- Click to view this document
EPA Regulations: Too Much, Too Little, or On Track? -- Click to view this document
Keystone XL Pipeline Project: Key Issues -- Click to view this document
Central America Regional Security Initiative: Background and Policy Issues for Congress -- Click to view this document
State Taxation of Internet Transactions -- Click to view this document
Federal Assistance for Wildfire Response and Recovery -- Click to view this document
The U.S. Export Control System and the President's Reform Initiative -- Click to view this document
DESIGNING A DIGITAL FUTURE: FEDERALLY FUNDED RESEARCH AND DEVELOPMENT IN NETWORKING AND INFORMATION TECHNOLOGY -- Click to view this document
Winning the Future With Science and Technology for 21st Century Smart Systems -- Click to view this document

For Power Users

FULL TEXT CRS DOCUMENTS

Find documents

Drugs, Biologics, and Medical Devices: A Compendium

This Compendium includes a wealth of reports on drugs, biologics and medical devices. The reports included consist of the authority to regulate drug compounding; the law and intellectual property rights of biologics; federal drug discovery and pricing; the FDA’s Safety and Innovation ACT (P.L. 112-114); effects on pharmaceutical innovation and effects of generic brands; infringement and experimental use under the Hatch-Waxman Act. Furthermore, the reauthorization of the Prescription Drug User Fee Act (PDUFA); and how the FDA approves drugs and regulates their safety and effectiveness.

Updated 4-Feb-2013

This package includes following files:

#	File Name	Document Date	Order ID:	Number of Pages	Price
1	C-12010 Drugs Biologics and Medical Devices C-12010.pdf	Feb 04, 2013	C12010	313	$79.95	Add to Cart